Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison

Sell

23

ALPMY
Astellas Pharma

Last Price:

10.13

Seasonality Move:

1.46%

Sell

49

SOLTF
Nxera Pharma

Last Price:

8.05

Seasonality Move:

14.44%

Sell

23

Astellas Pharma (ALPMY) is a Sell

Is Astellas Pharma a Buy, Sell or Hold?

The current Astellas Pharma [ALPMY] share price is $10.13. The Score for ALPMY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
ALPMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

49

Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALPMY Stock Price Chart

What is Astellas Pharma's stock price today?

The Astellas Pharma share price today is $10.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing slight selling pressure.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.

ALPMY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.39	Sell
Relative Strength Index (14 RSI):	28.15	Sell
Chaikin Money Flow:	-118144	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(10.62 - 11.76)	Sell
Bollinger Bands (100):	(10.69 - 12.17)	Sell

SOLTF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	52.73	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.32 - 8.02)	Buy
Bollinger Bands (100):	(8.01 - 10.11)	Sell

ALPMY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.47	Sell
20-day SMA:	11.08	Sell
50-day SMA:	11.51	Sell
200-day SMA:	10.83	Sell
8-day EMA:	10.45	Sell
20-day EMA:	10.9	Sell
50-day EMA:	11.28	Sell
200-day EMA:	11.38	Sell

SOLTF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.05	Sell
20-day SMA:	7.73	Buy
50-day SMA:	8.28	Sell
200-day SMA:	9.4	Sell
8-day EMA:	8.01	Buy
20-day EMA:	7.94	Buy
50-day EMA:	8.26	Sell
200-day EMA:	9.39	Sell

Astellas Pharma Earnings Growth & ALPMY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Astellas Pharma Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nxera Pharma Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):